Monitoring glycemic control in end-stage renal disease: What should be measured?

Elizabeth Selvin, David B. Sacks

Research output: Contribution to journalReview article

Original languageEnglish (US)
Pages (from-to)447-449
Number of pages3
JournalClinical Chemistry
Volume63
Issue number2
DOIs
StatePublished - Feb 1 2017

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Monitoring glycemic control in end-stage renal disease : What should be measured? / Selvin, Elizabeth; Sacks, David B.

In: Clinical Chemistry, Vol. 63, No. 2, 01.02.2017, p. 447-449.

Research output: Contribution to journalReview article

@article{3fc5cf9df71b4ecbbb324cf658cc205a,
title = "Monitoring glycemic control in end-stage renal disease: What should be measured?",
author = "Elizabeth Selvin and Sacks, {David B.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1373/clinchem.2016.265744",
language = "English (US)",
volume = "63",
pages = "447--449",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "2",

}

TY - JOUR

T1 - Monitoring glycemic control in end-stage renal disease

T2 - What should be measured?

AU - Selvin, Elizabeth

AU - Sacks, David B.

PY - 2017/2/1

Y1 - 2017/2/1

UR - http://www.scopus.com/inward/record.url?scp=85011536614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011536614&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2016.265744

DO - 10.1373/clinchem.2016.265744

M3 - Review article

C2 - 27974388

AN - SCOPUS:85011536614

VL - 63

SP - 447

EP - 449

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 2

ER -